Skip to content

Released Mar 22, 2018, during market hours

10-K filed Mar 28, 2018, 87 days after period end · 0001493152-18-004041

Q4 2017 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$4.15Mderived+441.2% vs Q4 2016+36.5% vs Q3 2017
Net Income-$217.00KderivedN/M vs Q4 2016N/M vs Q3 2017
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,291,000+165.1%
Operating Incomederived-$1,457,000N/M
Operating Cash Flowderived-$1,726,000N/M
Free Cash Flowderived-$1,732,000N/M
Margins · derived
Gross margin31.1%−32.4 pt vs Q4 2016
Operating margin-35.1%−134.3 pt vs Q4 2016
Net margin-5.2%+69.3 pt vs Q4 2016

What the release said

The release

Same quarter

MetricQ4 2017derived from reported figuresQ4 2016derived from reported figuresQ4 2015Q4 2014
Revenue$4.15M$767.00K$8.16M$8.97M
Net Income-$217.00K-$572.00K-$1.26M-$676.00K
EPS Diluted——-$0.07-$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR